Decisions 10th December 2013


Recent JFG Decisions

 

At the meeting on the 10th December 2013 the following decisions / changes to the formulary were agreed

 

New Drug Requests

Approved

 

Midazolam and Lignocaine

  • Approved for inclusion onto the formulary for intranasal administration for conscious sedation to enable dental treatment in adults when a titratable technique is not possible.  UHB only

 

Lactulose

  • Approved for inclusion onto the formulary for use as part of the Enhanced recovery Programme following colorectal resection, following insertion of colonic stent and post-surgery following minor anorectal surgery. 

  

Dundee sunscreen

  • Approved for inclusion onto the formulary as a sunscreen when visible light range causes photodamage in paediatric patients.  UHB only

 

Temocillin

  • Approved for inclusion onto the formulary for the treatment of sepsis/UTIs/Respiratory tract infections that are caused by susceptible gram negative bacilli.  TLS Red, UHB only, Restricted to Microbiology advice only. 

 

Pending

Tamoxifen

  • Approved for inclusion onto the formulary for the reduction in breast cancer incidence in people with a family history of breast, ovarian or related (prostate/pancreatic) cancer as recommended in NICE CG164, only after the patient has been identified, been appropriately counselled by and treatment recommended by the Bristol Breast Cancer Family History Service. 
  • This will be added to the formulary when the pathway for this cohort of patients has been agreed.

Ultibro

  • Approved for inclusion onto the formulary as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.
  • This will be added to the formulary when Ultibo becomes available for prescription - this is expected in Spring 2014.

 

Rejected

none

 

Deferred

none 

 

Specialised Commissioning

none 

 

Shared Care Protocols

 

Methotrexate in IBD

  • NBT and Weston
  • new SCP

Aripiprazole

  • AWP
  • updated SCP and agreement form 

Atypical Antipsychotic depots

  • AWP
  • amber 1 month
  • new SCP and agreement form

Denosumab

  • NBT/UHB/Weston
  • amber
  • updated SCP to include men

 

Change in TLS

 

Ranolazine

  • proposal to change in TLS status from red to amber 3 months provisionally agreed - await SCP to be signed off before this change is implemented.

 

 

Last updated by: on 07-01-2014 15:19